185 related articles for article (PubMed ID: 36923610)
1. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
2. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.
Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L
Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049
[TBL] [Abstract][Full Text] [Related]
3. Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
Takahashi Y; Mochizuki Y; Nakamura K; Katoh N; Sekijima Y
Intern Med; 2022 May; 61(10):1603-1608. PubMed ID: 34744103
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of Quasi-moyamoya Disease and POEMS Syndrome in a Patient with Intracranial Hemorrhage: A Case Report and Literature Review.
Yamaguchi I; Satomi J; Yamamoto N; Yoshioka S; Tada Y; Yagi K; Kanematsu Y; Nagahiro S
NMC Case Rep J; 2017 Jan; 4(1):5-9. PubMed ID: 28664017
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of different vascular reconstruction on adult moyamoya disease].
Pan SJ; Zhang Y; Hou Y; Wang JF; Chai HF; Zhao ZX; Hu XM; Zang YZ
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(13):998-1002. PubMed ID: 30955312
[No Abstract] [Full Text] [Related]
6. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
7. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
[TBL] [Abstract][Full Text] [Related]
8. Recurrent stroke due to quasi-moyamoya disease associated with POEMS syndrome: An autopsy case.
Sekiguchi T; Ishibashi S; Sasame J; Mukae JI; Noda K; Tanaka H; Yamamoto K; Takemoto Y; Kumagai J; Yokota T
J Neurol Sci; 2020 May; 412():116738. PubMed ID: 32092484
[No Abstract] [Full Text] [Related]
9. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results.
Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF
Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
11. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
12. Outcome Following Surgical Revascularization in Patients of Moyamoya Disease with Focus on Graft Patency and Angiographic Changes.
Gupta SK; Narayanan R; Aggarwal A; Mohanty M; Ahuja C; Verma N; Praneeth K; Agarwal V
Neurol India; 2021; 69(3):620-627. PubMed ID: 34169855
[TBL] [Abstract][Full Text] [Related]
13. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
Twigg J; Methley A; Lavin T; Dickinson G; Teager A
Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.
Thines L; Petyt G; Aguettaz P; Bodenant M; Himpens FX; Lenci H; Henon H; Gauthier C; Hossein-Foucher C; Cordonnier C; Lejeune JP
Rev Neurol (Paris); 2015 Jan; 171(1):31-44. PubMed ID: 25555850
[TBL] [Abstract][Full Text] [Related]
15. Superficial temporal artery-to-middle cerebral artery anastomosis with encephalo-duro-myo-synangiosis as a modified operative procedure for moyamoya disease.
Ishii K; Morishige M; Anan M; Sugita K; Abe E; Kubo T; Fujiki M; Kobayashi H
Acta Neurochir Suppl; 2010; 107():95-9. PubMed ID: 19953378
[TBL] [Abstract][Full Text] [Related]
16. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
18. Treatment-responsive glycogen storage myopathy in a patient with POEMS syndrome: A new monoclonal gammopathy-associated myopathy.
Soontrapa P; Tracy JA; Gonsalves WI; Liewluck T
Eur J Neurol; 2023 Oct; 30(10):3404-3406. PubMed ID: 37522432
[TBL] [Abstract][Full Text] [Related]
19. Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?
Houkin K; Kuroda S; Ishikawa T; Abe H
Acta Neurochir (Wien); 2000; 142(3):269-76. PubMed ID: 10819257
[TBL] [Abstract][Full Text] [Related]
20. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
